Armstrong, Fleming & Moore »

Biogen Idec shares owned by Armstrong, Fleming & Moore

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Armstrong, Fleming & Moore from 13F filings

Historical chart of Armstrong, Fleming & Moore investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Armstrong, Fleming & Moore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Armstrong, Fleming & Moore

Quarter filed Position value Share count Share price at filing
2024-03-31 $374k 1.7k 215.68
2023-12-31 $449k 1.7k 258.83
2023-09-30 $446k 1.7k 257.07
2023-06-30 $494k 1.7k 284.92